Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Stay updated on the latest trends and innovations in the clinical trials industry. Explore expert insights and news to stay ahead. Visit us now!
News
Definium's psychedelic prospects brighten further on Phase III success
DT120 has now posted positive results in both GAD and MDD, setting the stage for its potential foray into the neuropsychiatric market.The post Definium's psychedelic prospects brighten further on Phase III success appeared first on Clinical Trials Arena.
Read more
Report
Belenos' Keymed licensing deal delivers on Phase II win in rhinosinusitis
Belenos and Keymed will now look to initiate Phase III studies for their co-developed drug in Dupixent-dominated CRSwNP.The post Belenos' Keymed licensing deal delivers on Phase II win in rhinosinusitis appeared first on Clinical Trials Arena.
Read more
Report
Why your manufacturing floor is your greatest compliance risk - and opportunity
The manufacturing floor represents the primary source of life sciences compliance risks and data integrity failures.The post Why your manufacturing floor is your greatest compliance risk - and opportunity appeared first on Clinical Trials Arena.
Read more
Report
Investigational CRISPR therapy succeeds in patient with drug-resistant E. Coli
The CRISPR therapy, SNIPR001, was administered to the patient who had developed E. Coli following a single-patient emergency IND.The post Investigational CRISPR therapy succeeds in patient with drug-resistant E. Coli appeared first on Clinical Trials Aren
Read more
Report
Arch Biopartners plans US expansion of LSALT peptide trial
Arch Biopartners is set to expand its Phase II clinical trial of LSALT peptide, a drug candidate targeting CS-AKI, to clinical sites in the US.The post Arch Biopartners plans US expansion of LSALT peptide trial appeared first on Clinical Trials Arena.
Read more
Report
Pro access
Upgrade to see all 20 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.